Reactions 1680, p324 - 2 Dec 2017 Hypoglycaemia: case report In a prospective, observational, multicenter, post-marketing study (J-STEP/EL) of 1,535 patients, 1424 patients were analysed, out of whom one elderly patient [exact age an sex not stated] developed hypoglycaemia during treatment with tofogliflozin. The patient had a diagnosis of type 2 diabetes mellitus and the patient received tofogliflozin 20mg tablet monotherapy. Within the first 2 weeks of tofogliflozin therapy, the patient developed hypoglycaemia, which was considered to be related with tofogliflozin [outcome not stated]. Author comment: "One patient took tofogliflozin as monotherapy, and hypoglycemia occurred within the first 2 weeks." Utsunomiya K, et al. Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post-marketing study (J-STEP/EL Study). Journal of Diabetes Investigation 8: 766-775, No. 6, Nov 2017. Available from: URL: http://doi.org/10.1111/jdi.12626 - Japan 803284366 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera